Medical devices, healthcare technology and the business of care
510(k) clearance · K240934

Quantum Perfusion Blood Oxygenator ECC VT160-E3 (VT160-E3); Quantum Perfusion Blood Oxygenator ECC VT200-E3 (VT200-E3); Quantum Perfusion Blood Oxygenator VT75- E3 (VT75- E3);

Spectrum Medical S.R.L. · Decision date Mar 12, 2026

FDA DECISIONK240934

What did the FDA decide?

FDA records K240934 as a 510(k) premarket notification, with a decision dated Mar 12, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Mar 12, 2026

FDA source record

Regulatory record facts

Identifier
K240934
Regulatory pathway
510(k) premarket notification
Product code
DTZ
Decision code
SESE
Decision date
Mar 12, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Oxygenator, Cardiopulmonary Bypass.

Product code
DTZ
FDA device class
2

FDA decision timeline

  1. K240934 received

    Application receipt date recorded by FDA.

  2. K240934 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DTZ

Product / regulatory recordCompanyPathwayDecision dateSource
Eurosets S.R.L510(k) clearanceSep 14, 2026FDA
Lifemotion Medical Technology Co., Ltd.510(k) clearanceMar 16, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Spectrum Medical S.R.L.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Mirandola

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records